Author:
Sattler Sonja,Gollomp Stephen,Curry Andrew
Reference17 articles.
1. Human albumin solutions in intensive care: A review.;Melia;J Intensive Care Soc.,2021
2. Use of albumin in the NICU: An evidence-based review.;Rustogi;Neoreviews.,2022
3. Safety of human albumin–serious adverse events reported worldwide in 1998–2000.;Vincent;Br J Anaesth.,2003
4. An investigation of possible immunologic reactions to human serum albumin used as a stabilizer in allergy extracts.;Brown;J Allergy Clin Immunol.,1985
5. U.S. Food and Drug Administration. Revised Preventive Measures Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creudtzfeld-Jakob Disease by Blood and Blood Products. Silver Spring, MD; 2016. Available at: http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default